Participant Outcomes of a Student-Run, Intensive, Short-Term, Task-Specific Rehabilitation Program for Individuals Post-Stroke.

Stroke survivors continue to face chronic disability and limited access to early, continuous, and long-term rehabilitation. This pilot study examined the impact of a 6-day, intensive, short-term, task-specific rehabilitation program (ISTRP) on outcomes post-stroke as part of a service-learning experience (SLE) for Doctor of Physical Therapy (DPT) students. Participants (n=19) post-stroke completed a 6-day, student-led ISTRP.

Sleeve gastrectomy to aortic valve replacement: safe?

Background: Bariatric surgery has favorable results on cardiac structure and function, but there is minimal research on its utility in the cardiac comorbid population.

Objectives: To determine if laparoscopic sleeve gastrectomy (SG) is safe in patients with symptomatic aortic stenosis (AS).

Setting: Community hospital/bariatric center of excellence in Pennsylvania.

Perioperative Multimodal Anesthetic Care Incorporating Transversus Abdominis Plane Block Is Associated With Reduced Narcotic Use in Laparoscopic Sleeve Gastrectomy.

Background: Laparoscopic sleeve gastrectomy (LSG) is the most commonly performed bariatric surgery performed in North America. As our knowledge of the importance in limiting narcotic use in postoperative patients increases, we sought to evaluate the effect of transversus abdominis plane (TAP) blocks on inpatient narcotic use in patients undergoing LSG.

Methods: A retrospective review of LSG performed at a single institution by 3 bariatric surgeons was performed.

An unusual presentation of acute cholecystitis: gallbladder volvulus.

Gallbladder volvulus is a rare condition with similar presentation to acute cholecystitis. It is caused by the gallbladder twisting upon its mesentery leading to potential ischemia and biliary obstruction. A 77-year-old female presented with symptoms of right upper quadrant pain and nausea.

Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.

Over the last decade, the use of biomarker data has become integral to drug development. Biomarkers are not only utilized for internal decision-making by sponsors; they are increasingly utilized to make critical decisions for drug safety and efficacy. As the regulatory agencies are routinely making decisions based on biomarker data, there has been significant scrutiny on the validation of biomarker methods.